ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
3.46
-0.10 (-2.81%)
At close: Sep 25, 2025, 10:09 AM
ADC Therapeutics S.A. Revenue
ADC Therapeutics S.A. reported an annual revenue of $70.84M, reflecting a 1.84% growth. For the quarter ending June 30, 2025, ADC Therapeutics S.A. generated $18.84M in revenue.
Revenue (ttm)
70.84M
Revenue Growth
1.84%
Price / Sales Ratio
2.73
Revenue / Employee
269.34K
Employees
263
Market Cap
389.25M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 70.84M | +1.84% |
| Dec 31, 2023 | 69.56M | -66.86% |
| Dec 31, 2022 | 209.91M | +518.89% |
| Dec 31, 2021 | 33.92M | +Infinity% |
| Dec 31, 2020 | 0 | -100.00% |
| Dec 31, 2019 | 2.34M | +105.26% |
| Dec 31, 2018 | 1.14M | -36.77% |
| Dec 31, 2017 | 1.8M | n/a |